Business
Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees
BioReference initiates COVID-19 testing for all Major League Soccer players, match officials, and Club and League employees participating in the MLS is Back
About this update from Opko Health, Inc.
[{"type":"text","content":"BioReference initiates COVID-19 testing for all Major League Soccer players, match officials, and Club and League employees participating in the MLS is Back Tournament\n MLS will support COVID-19 antibody testing for the Orlando community utilizing BioReference's community collection program\n\n\nELMWOOD PARK, N.J., July 9, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), will conduct COVID-19 testing for all Major League Soccer (MLS) players as well as match officials, and Club and League staff participating in the MLS is Back Tournament. MLS has chosen BioReference as its laboratory to assist in informing its return-to-play policies for the Tournament kicking off in Orlando in early July. \n\n \n \n \n \n \n \n\n \nIn addition to providing testing to players, match officials, and staff, MLS is working with BioReference to provide COVID-19 antibody testing to the Orlando community. MLS is supporting the latest community collection location at the Orlando Vineland Premium Outlets, which began on July 6. The collection location is open Mondays through Saturdays from 8:00 AM to 6:00 PM ET. \n\"We are honored to be providing testing solutions to Major League Soccer as it prepares to restart its season,\" said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. \"The leadership of MLS worked diligently with us to develop a COVID-19 PCR and antibody testing strategy with the goal of providing the safest possible environment for the players, coaches and staff to begin to play again.\"\nFor more information, visit https://www.bioreference.com/coronavirus/employers-and-government-authorities/. \nAbout BioReference Laboratories, Inc.BioReference provides comprehensive testing to physicians, clinics, hospitals, employers, government units, correctional institutions and medical groups. BioReference has been working expeditiously to develop and offer test services that will yield high quality and accurate results, including a molecular test for helping with COVID-19 diagnosis and a serology test to help indicate possible COVID-19 exposure. The company is in network with the five largest health plans in the United States, operates a network of 11 laboratory locations, and is backed by a medical staff of more than 120 M.D., Ph.D. and other professional level clinicians and scientists...